Cigna Corporation Logo

Cigna Corporation

CGN.DE

(2.0)
Stock Price

304,60 EUR

4.62% ROA

8.11% ROE

27.17x PER

Market Cap.

97.834.261.785,40 EUR

79.57% DER

1.45% Yield

1.77% NPM

Cigna Corporation Stock Analysis

Cigna Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Cigna Corporation Fundamental Stock Analysis
# Analysis Rating
1 Revenue Growth

This company's revenue has experienced steady growth over the last five years, indicating a reliable and prosperous financial trajectory.

2 ROE

ROE in an average range (11.75%) suggests satisfactory profitability and decent utilization of shareholders' equity.

3 ROA

The stock's ROA (7.31%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

4 PBV

The stock's PBV ratio (1.81x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

5 DER

The stock maintains a fair debt to equity ratio (68%), indicating a reasonable balance between the money it owes and the ownership it possesses.

6 Dividend

Investors can rely on the company's consistent dividend payments over the past three years, offering a steady stream of returns.

7 Buffet Intrinsic Value

The company's stock seems undervalued (11.590) by Warren Buffett's formula, indicating a promising investment opportunity as its intrinsic value exceeds the market price.

8 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

9 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

10 Graham Number

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

11 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

Cigna Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Cigna Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Cigna Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Cigna Corporation Revenue
Year Revenue Growth
1985 0
1986 0 0%
1987 0 0%
1988 0 0%
1989 11.494.000.000 100%
1990 13.986.000.000 17.82%
1991 14.295.000.000 2.16%
1992 13.924.000.000 -2.66%
1993 13.712.000.000 -1.55%
1994 18.392.000.000 25.45%
1995 18.955.000.000 2.97%
1996 18.950.000.000 -0.03%
1997 20.038.000.000 5.43%
1998 21.437.000.000 6.53%
1999 18.781.000.000 -14.14%
2000 19.994.000.000 6.07%
2001 19.115.000.000 -4.6%
2002 19.348.000.000 1.2%
2003 18.808.000.000 -2.87%
2004 18.176.000.000 -3.48%
2005 16.684.000.000 -8.94%
2006 16.547.000.000 -0.83%
2007 17.623.000.000 6.11%
2008 19.101.000.000 7.74%
2009 18.414.000.000 -3.73%
2010 21.253.000.000 13.36%
2011 21.998.000.000 3.39%
2012 29.119.000.000 24.45%
2013 32.380.000.000 10.07%
2014 34.914.000.000 7.26%
2015 37.876.000.000 7.82%
2016 39.668.000.000 4.52%
2017 42.043.000.000 5.65%
2018 48.569.000.000 13.44%
2019 153.743.000.000 68.41%
2020 160.577.000.000 4.26%
2021 174.272.000.000 7.86%
2022 180.642.000.000 3.53%
2023 196.156.000.000 7.91%
2023 195.187.000.000 -0.5%
2024 221.676.000.000 11.95%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Cigna Corporation Research and Development Expenses
Year Research and Development Expenses Growth
1985 0
1986 0 0%
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Cigna Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
1985 0
1986 0 0%
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 5.535.000.000 100%
2009 5.450.000.000 -1.56%
2010 5.744.000.000 5.12%
2011 5.901.000.000 2.66%
2012 0 0%
2013 7.566.000.000 100%
2014 0 0%
2015 0 0%
2016 0 0%
2017 9.831.000.000 100%
2018 11.934.000.000 17.62%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Cigna Corporation EBITDA
Year EBITDA Growth
1985 -854.900.000
1986 700.900.000 221.97%
1987 833.000.000 15.86%
1988 570.100.000 -46.11%
1989 696.000.000 18.09%
1990 364.000.000 -91.21%
1991 580.000.000 37.24%
1992 153.000.000 -279.08%
1993 165.000.000 7.27%
1994 805.000.000 79.5%
1995 251.000.000 -220.72%
1996 1.601.000.000 84.32%
1997 1.905.000.000 15.96%
1998 2.328.000.000 18.17%
1999 2.519.000.000 7.58%
2000 1.730.000.000 -45.61%
2001 1.741.000.000 0.63%
2002 -349.000.000 598.85%
2003 1.197.000.000 129.16%
2004 2.466.000.000 51.46%
2005 2.363.000.000 -4.36%
2006 1.935.000.000 -22.12%
2007 1.820.000.000 -6.32%
2008 626.000.000 -190.73%
2009 2.164.000.000 71.07%
2010 2.340.000.000 7.52%
2011 2.514.000.000 6.92%
2012 3.036.000.000 17.19%
2013 3.035.000.000 -0.03%
2014 3.900.000.000 22.18%
2015 3.929.000.000 0.74%
2016 3.613.000.000 -8.75%
2017 4.429.000.000 18.42%
2018 4.765.000.000 7.05%
2019 -92.894.000.000 105.13%
2020 -94.130.000.000 1.31%
2021 -111.758.000.000 15.77%
2022 6.668.000.000 1776.03%
2023 -127.864.000.000 105.21%
2023 -128.903.000.000 0.81%
2024 -8.968.000.000 -1337.37%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Cigna Corporation Gross Profit
Year Gross Profit Growth
1985 0
1986 0 0%
1987 0 0%
1988 0 0%
1989 11.494.000.000 100%
1990 13.986.000.000 17.82%
1991 14.295.000.000 2.16%
1992 13.924.000.000 -2.66%
1993 13.712.000.000 -1.55%
1994 18.392.000.000 25.45%
1995 18.955.000.000 2.97%
1996 18.950.000.000 -0.03%
1997 20.038.000.000 5.43%
1998 21.437.000.000 6.53%
1999 18.781.000.000 -14.14%
2000 19.994.000.000 6.07%
2001 19.115.000.000 -4.6%
2002 19.348.000.000 1.2%
2003 18.808.000.000 -2.87%
2004 18.176.000.000 -3.48%
2005 16.684.000.000 -8.94%
2006 16.547.000.000 -0.83%
2007 17.623.000.000 6.11%
2008 19.101.000.000 7.74%
2009 18.414.000.000 -3.73%
2010 21.253.000.000 13.36%
2011 21.998.000.000 3.39%
2012 29.119.000.000 24.45%
2013 32.380.000.000 10.07%
2014 34.914.000.000 7.26%
2015 37.876.000.000 7.82%
2016 39.668.000.000 4.52%
2017 42.043.000.000 5.65%
2018 48.569.000.000 13.44%
2019 153.743.000.000 68.41%
2020 160.577.000.000 4.26%
2021 174.272.000.000 7.86%
2022 180.642.000.000 3.53%
2023 196.156.000.000 7.91%
2023 195.187.000.000 -0.5%
2024 229.020.000.000 14.77%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Cigna Corporation Net Profit
Year Net Profit Growth
1985 -854.600.000
1986 534.900.000 259.77%
1987 685.600.000 21.98%
1988 472.200.000 -45.19%
1989 562.000.000 15.98%
1990 330.000.000 -70.3%
1991 449.000.000 26.5%
1992 311.000.000 -44.37%
1993 234.000.000 -32.91%
1994 554.000.000 57.76%
1995 211.000.000 -162.56%
1996 1.056.000.000 80.02%
1997 1.086.000.000 2.76%
1998 1.292.000.000 15.94%
1999 1.774.000.000 27.17%
2000 987.000.000 -79.74%
2001 989.000.000 0.2%
2002 -398.000.000 348.49%
2003 668.000.000 159.58%
2004 1.438.000.000 53.55%
2005 1.625.000.000 11.51%
2006 1.155.000.000 -40.69%
2007 1.115.000.000 -3.59%
2008 292.000.000 -281.85%
2009 1.302.000.000 77.57%
2010 1.345.000.000 3.2%
2011 1.327.000.000 -1.36%
2012 1.623.000.000 18.24%
2013 1.476.000.000 -9.96%
2014 2.102.000.000 29.78%
2015 2.094.000.000 -0.38%
2016 1.867.000.000 -12.16%
2017 2.237.000.000 16.54%
2018 2.637.000.000 15.17%
2019 5.104.000.000 48.33%
2020 8.458.000.000 39.65%
2021 5.370.000.000 -57.5%
2022 6.704.000.000 19.9%
2023 5.632.000.000 -19.03%
2023 5.164.000.000 -9.06%
2024 -1.108.000.000 566.06%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Cigna Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1985 -1
1986 1 0%
1987 1 0%
1988 1 0%
1989 1 0%
1990 0 0%
1991 1 0%
1992 0 0%
1993 0 0%
1994 1 0%
1995 0 0%
1996 2 100%
1997 2 0%
1998 2 50%
1999 3 33.33%
2000 2 -200%
2001 2 50%
2002 -1 0%
2003 2 100%
2004 4 66.67%
2005 4 25%
2006 3 -33.33%
2007 4 0%
2008 1 -200%
2009 5 75%
2010 5 0%
2011 5 0%
2012 6 20%
2013 5 0%
2014 8 28.57%
2015 8 12.5%
2016 7 -14.29%
2017 9 22.22%
2018 11 10%
2019 14 23.08%
2020 23 43.48%
2021 16 -53.33%
2022 20 21.05%
2023 19 0%
2023 18 -11.76%
2024 -4 666.67%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Cigna Corporation Free Cashflow
Year Free Cashflow Growth
1989 1.402.000.000
1990 1.011.000.000 -38.67%
1991 744.000.000 -35.89%
1992 696.000.000 -6.9%
1993 1.120.000.000 37.86%
1994 475.000.000 -135.79%
1995 1.104.000.000 56.97%
1996 700.000.000 -57.71%
1997 1.231.000.000 43.14%
1998 627.000.000 -96.33%
1999 -1.633.000.000 138.4%
2000 1.685.000.000 196.91%
2001 1.086.000.000 -55.16%
2002 1.075.000.000 -1.02%
2003 2.201.000.000 51.16%
2004 1.398.000.000 -57.44%
2005 657.000.000 -112.79%
2006 506.000.000 -29.84%
2007 1.080.000.000 53.15%
2008 1.399.000.000 22.8%
2009 438.000.000 -219.41%
2010 1.443.000.000 69.65%
2011 1.069.000.000 -34.99%
2012 1.942.000.000 44.95%
2013 192.000.000 -911.46%
2014 1.521.000.000 87.38%
2015 2.207.000.000 31.08%
2016 3.565.000.000 38.09%
2017 3.615.000.000 1.38%
2018 3.242.000.000 -11.51%
2019 8.435.000.000 61.56%
2020 9.256.000.000 8.87%
2021 6.037.000.000 -53.32%
2022 7.361.000.000 17.99%
2023 10.240.000.000 28.12%
2023 2.423.000.000 -322.62%
2024 4.540.000.000 46.63%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Cigna Corporation Operating Cashflow
Year Operating Cashflow Growth
1989 1.402.000.000
1990 1.011.000.000 -38.67%
1991 744.000.000 -35.89%
1992 696.000.000 -6.9%
1993 1.120.000.000 37.86%
1994 475.000.000 -135.79%
1995 1.104.000.000 56.97%
1996 700.000.000 -57.71%
1997 1.231.000.000 43.14%
1998 627.000.000 -96.33%
1999 1.817.000.000 65.49%
2000 1.685.000.000 -7.83%
2001 1.086.000.000 -55.16%
2002 1.378.000.000 21.19%
2003 2.308.000.000 40.29%
2004 1.436.000.000 -60.72%
2005 718.000.000 -100%
2006 642.000.000 -11.84%
2007 1.342.000.000 52.16%
2008 1.656.000.000 18.96%
2009 745.000.000 -122.28%
2010 1.743.000.000 57.26%
2011 1.491.000.000 -16.9%
2012 2.350.000.000 36.55%
2013 719.000.000 -226.84%
2014 1.994.000.000 63.94%
2015 2.717.000.000 26.61%
2016 4.026.000.000 32.51%
2017 4.086.000.000 1.47%
2018 3.770.000.000 -8.38%
2019 9.485.000.000 60.25%
2020 10.350.000.000 8.36%
2021 7.191.000.000 -43.93%
2022 8.656.000.000 16.92%
2023 11.813.000.000 26.72%
2023 2.826.000.000 -318.01%
2024 4.840.000.000 41.61%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Cigna Corporation Capital Expenditure
Year Capital Expenditure Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 3.450.000.000 100%
2000 0 0%
2001 0 0%
2002 303.000.000 100%
2003 107.000.000 -183.18%
2004 38.000.000 -181.58%
2005 61.000.000 37.7%
2006 136.000.000 55.15%
2007 262.000.000 48.09%
2008 257.000.000 -1.95%
2009 307.000.000 16.29%
2010 300.000.000 -2.33%
2011 422.000.000 28.91%
2012 408.000.000 -3.43%
2013 527.000.000 22.58%
2014 473.000.000 -11.42%
2015 510.000.000 7.25%
2016 461.000.000 -10.63%
2017 471.000.000 2.12%
2018 528.000.000 10.8%
2019 1.050.000.000 49.71%
2020 1.094.000.000 4.02%
2021 1.154.000.000 5.2%
2022 1.295.000.000 10.89%
2023 1.573.000.000 17.67%
2023 403.000.000 -290.32%
2024 300.000.000 -34.33%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Cigna Corporation Equity
Year Equity Growth
1985 3.754.000.000
1986 4.625.000.000 18.83%
1987 4.973.000.000 7%
1988 5.237.600.000 5.05%
1989 5.520.000.000 5.12%
1990 5.242.000.000 -5.3%
1991 5.863.000.000 10.59%
1992 5.744.000.000 -2.07%
1993 6.575.000.000 12.64%
1994 5.811.000.000 -13.15%
1995 7.157.000.000 18.81%
1996 7.208.000.000 0.71%
1997 7.932.000.000 9.13%
1998 8.277.000.000 4.17%
1999 6.149.000.000 -34.61%
2000 5.413.000.000 -13.6%
2001 5.055.000.000 -7.08%
2002 3.867.000.000 -30.72%
2003 4.519.000.000 14.43%
2004 5.203.000.000 13.15%
2005 5.360.000.000 2.93%
2006 4.330.000.000 -23.79%
2007 4.748.000.000 8.8%
2008 3.592.000.000 -32.18%
2009 5.429.000.000 33.84%
2010 6.663.000.000 18.52%
2011 8.344.000.000 20.15%
2012 9.883.000.000 15.57%
2013 10.677.000.000 7.44%
2014 10.879.000.000 1.86%
2015 12.113.000.000 10.19%
2016 13.785.000.000 12.13%
2017 13.784.000.000 -0.01%
2018 41.072.000.000 66.44%
2019 45.379.000.000 9.49%
2020 50.386.000.000 9.94%
2021 47.184.000.000 -6.79%
2022 44.951.000.000 -4.97%
2023 45.766.000.000 1.78%
2023 46.351.000.000 1.26%
2024 41.350.000.000 -12.09%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Cigna Corporation Assets
Year Assets Growth
1985 44.736.200.000
1986 50.015.800.000 10.56%
1987 53.495.200.000 6.5%
1988 55.824.500.000 4.17%
1989 57.779.000.000 3.38%
1990 63.691.000.000 9.28%
1991 66.737.000.000 4.56%
1992 69.827.000.000 4.43%
1993 84.975.000.000 17.83%
1994 86.102.000.000 1.31%
1995 95.903.000.000 10.22%
1996 98.932.000.000 3.06%
1997 108.199.000.000 8.56%
1998 114.612.000.000 5.6%
1999 95.333.000.000 -20.22%
2000 95.088.000.000 -0.26%
2001 91.589.000.000 -3.82%
2002 88.950.000.000 -2.97%
2003 90.953.000.000 2.2%
2004 81.059.000.000 -12.21%
2005 44.863.000.000 -80.68%
2006 42.399.000.000 -5.81%
2007 40.065.000.000 -5.83%
2008 41.406.000.000 3.24%
2009 43.013.000.000 3.74%
2010 45.682.000.000 5.84%
2011 51.047.000.000 10.51%
2012 53.734.000.000 5%
2013 54.336.000.000 1.11%
2014 55.896.000.000 2.79%
2015 57.088.000.000 2.09%
2016 59.360.000.000 3.83%
2017 61.753.000.000 3.88%
2018 153.226.000.000 59.7%
2019 155.774.000.000 1.64%
2020 155.451.000.000 -0.21%
2021 154.889.000.000 -0.36%
2022 143.932.000.000 -7.61%
2023 149.645.000.000 3.82%
2023 152.761.000.000 2.04%
2024 153.119.000.000 0.23%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Cigna Corporation Liabilities
Year Liabilities Growth
1985 40.982.200.000
1986 45.390.800.000 9.71%
1987 48.522.200.000 6.45%
1988 50.586.900.000 4.08%
1989 52.259.000.000 3.2%
1990 58.449.000.000 10.59%
1991 60.874.000.000 3.98%
1992 64.083.000.000 5.01%
1993 78.400.000.000 18.26%
1994 80.291.000.000 2.36%
1995 88.746.000.000 9.53%
1996 91.724.000.000 3.25%
1997 100.267.000.000 8.52%
1998 106.335.000.000 5.71%
1999 89.184.000.000 -19.23%
2000 89.675.000.000 0.55%
2001 86.534.000.000 -3.63%
2002 85.083.000.000 -1.71%
2003 86.434.000.000 1.56%
2004 75.856.000.000 -13.94%
2005 39.503.000.000 -92.03%
2006 38.069.000.000 -3.77%
2007 35.317.000.000 -7.79%
2008 37.814.000.000 6.6%
2009 37.584.000.000 -0.61%
2010 39.019.000.000 3.68%
2011 42.703.000.000 8.63%
2012 43.851.000.000 2.62%
2013 43.659.000.000 -0.44%
2014 45.017.000.000 3.02%
2015 44.975.000.000 -0.09%
2016 45.575.000.000 1.32%
2017 47.969.000.000 4.99%
2018 112.154.000.000 57.23%
2019 110.395.000.000 -1.59%
2020 105.065.000.000 -5.07%
2021 107.705.000.000 2.45%
2022 98.981.000.000 -8.81%
2023 103.879.000.000 4.72%
2023 106.410.000.000 2.38%
2024 111.769.000.000 4.79%

Cigna Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
714.89
Net Income per Share
12.68
Price to Earning Ratio
27.17x
Price To Sales Ratio
0.48x
POCF Ratio
8.46
PFCF Ratio
9.63
Price to Book Ratio
2.39
EV to Sales
0.6
EV Over EBITDA
-1.21
EV to Operating CashFlow
10.51
EV to FreeCashFlow
12.02
Earnings Yield
0.04
FreeCashFlow Yield
0.1
Market Cap
97,83 Bil.
Enterprise Value
122,16 Bil.
Graham Number
202.81
Graham NetNet
-291.69

Income Statement Metrics

Net Income per Share
12.68
Income Quality
3.02
ROE
0.08
Return On Assets
0.02
Return On Capital Employed
-0.69
Net Income per EBT
0.91
EBT Per Ebit
-0.04
Ebit per Revenue
-0.49
Effective Tax Rate
0.03

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
1.01
Operating Profit Margin
-0.49
Pretax Profit Margin
0.02
Net Profit Margin
0.02

Dividends

Dividend Yield
0.01
Dividend Yield %
1.45
Payout Ratio
0.41
Dividend Per Share
5.01

Operating Metrics

Operating Cashflow per Share
40.71
Free CashFlow per Share
35.58
Capex to Operating CashFlow
0.13
Capex to Revenue
0.01
Capex to Depreciation
0.48
Return on Invested Capital
-1.29
Return on Tangible Assets
0.05
Days Sales Outstanding
45.12
Days Payables Outstanding
-1613.87
Days of Inventory on Hand
0
Receivables Turnover
8.09
Payables Turnover
-0.23
Inventory Turnover
0
Capex per Share
5.13

Balance Sheet

Cash per Share
33,43
Book Value per Share
144,21
Tangible Book Value per Share
-116.96
Shareholders Equity per Share
144.21
Interest Debt per Share
119.68
Debt to Equity
0.8
Debt to Assets
0.21
Net Debt to EBITDA
-0.24
Current Ratio
0.95
Tangible Asset Value
-33,40 Bil.
Net Current Asset Value
-103,33 Bil.
Invested Capital
77938000000
Working Capital
-0,42 Bil.
Intangibles to Total Assets
0.49
Average Receivables
24,46 Bil.
Average Payables
8,34 Bil.
Average Inventory
0
Debt to Market Cap
0.33

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Cigna Corporation Dividends
Year Dividends Growth
2011 0
2012 0 0%
2020 0 0%
2021 4 100%
2022 4 0%
2023 5 0%
2024 4 -33.33%

Cigna Corporation Profile

About Cigna Corporation

Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

CEO
Mr. David Michael Cordani
Employee
70.325
Address
900 Cottage Grove Road
Bloomfield, 06002

Cigna Corporation Executives & BODs

Cigna Corporation Executives & BODs
# Name Age
1 Mr. David Michael Cordani
President, Chief Executive Officer & Chair of the Board
70
2 Mr. Christopher DeRosa M.B.A.
President of U.S. Government - Healthcare's Medicare & Individual & Family Plan (IFP) Businesses
70
3 Mr. Eric Paul Palmer
Executive Vice President of Enterprise Strategy
70
4 Mr. Ralph Giacobbe
Senior Vice President & Head of Investor Relations
70
5 Ms. Noelle K. Eder
Executive Vice President & Global Chief Information Officer
70
6 Ms. Jamie Kates
Chief Accounting Officer
70
7 Mr. Brian C. Evanko
Executive Vice President, Chief Financial Officer and President & Chief Executive Officer for Cigna Healthcare
70
8 Ms. Nicole Susan Jones
Executive Vice President, Chief Administrative Officer & General Counsel
70
9 Kari Knight Stevens
Executive Vice President, Chief Human Resources Officer & Corporate Secretary
70
10 Mr. Jason D. Sadler
President of International MArkets & President of International Health Cigna Healthcare
70

Cigna Corporation Competitors